NYSE: XPOFXponential Fitness Inc Stock
$15.25-0.24 (-1.55%)
Updated Dec 5, 2024
XPOF Price
$15.25
Fair Value Price
N/A
Market Cap
$736.62M
52 Week Low
$7.40
52 Week High
$18.95
P/E
-19.55x
P/B
-4.73x
P/S
1.22x
PEG
N/A
Dividend Yield
N/A
Revenue
$326.72M
Earnings
-$29.89M
Gross Margin
66.7%
Operating Margin
5.3%
Profit Margin
-9.1%
Debt to Equity
-3.82
Operating Cash Flow
$8M
Beta
1.57
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
XPOF Overview
Xponential Fitness Incorporated is a fitness franchisor in the U.S. and internationally. The company offers fitness and wellness services including pilates, barre, cycling, stretching, rowing, yoga, boxing, dancing, running, and functional training under the Club Pilates, Pure Barre, CycleBar, StretchLab, Row House, YogaSix, Rumble, AKT, Stride, and BFT brands. As of 2021/12/31, 1,556 franchisees operating almost 2,000 studios. Exponential Fitness was founded in 2017 and is headquartered in Irvine, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine XPOF's potential to beat the market
CHold
- Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More
Zen Rating Component Grades
B
Value
C
Growth
C
Momentum
F
Sentiment
C
Safety
C
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Leisure
Industry Rating
C
XPOF
Ranked#18 of 28
Ranked#18 of 28
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $28.85 | B | |
| $11.87 | B | |
| $20.02 | B |
Be the first to know about important XPOF news, forecast changes, insider trades & much more!
XPOF News
Overview
Due Diligence Score
–
Industry Average (25)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how XPOF scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
XPOF is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
XPOF is unprofitable, so we are unable to assess its PEG ratio
PEG Value Valuation
XPOF's Earnings (EBIT) of $17.33M... subscribe to Premium to read more.
Interest Coverage Financials
There are 30 more XPOF due diligence checks available for Premium users.
Valuation
XPOF price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-19.55x
Industry
10.15x
Market
29.14x
XPOF price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
-4.73x
Industry
3.6x
XPOF's financial health
Profit margin
Revenue
$80.5M
Net Income
-$12.0M
Profit Margin
-14.9%
XPOF's Earnings (EBIT) of $17.33M... subscribe to Premium to read more.
Interest Coverage Financials
XPOF's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$472.2M
Liabilities
$595.5M
Debt to equity
-3.82
XPOF's short-term assets ($95.58M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
XPOF's long-term liabilities ($501.37M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
XPOF's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
XPOF's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$5.2M
Investing
-$2.2M
Financing
$8.7M
XPOF's operating cash flow ($8.14M)... subscribe to Premium to read more.
Debt Coverage Financials
XPOF vs Leisure Stocks
Xponential Fitness Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.